| Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1 SCW Ling, EKK Lau, A Al-Shabeeb, A Nikolic, A Catalano, H Iland, ... Haematologica 97 (1), 64, 2012 | 152 | 2012 |
| Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes M Garcia-Contreras, SH Shah, A Tamayo, PD Robbins, RB Golberg, ... Scientific reports 7 (1), 5998, 2017 | 149 | 2017 |
| Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era AAS Akil, E Yassin, A Al-Maraghi, E Aliyev, K Al-Malki, KA Fakhro Journal of translational medicine 19 (1), 137, 2021 | 90 | 2021 |
| Coxsackievirus B5 infection induces dysregulation of microRNAs predicted to target known type 1 diabetes risk genes in human pancreatic islets KW Kim, A Ho, A Alshabee-Akil, AA Hardikar, TWH Kay, WD Rawlinson, ... Diabetes 65 (4), 996-1003, 2016 | 53 | 2016 |
| Children with islet autoimmunity and enterovirus infection demonstrate a distinct cytokine profile WCG Yeung, A Al-Shabeeb, CNI Pang, MR Wilkins, J Catteau, ... Diabetes 61 (6), 1500-1508, 2012 | 51 | 2012 |
| A systematic review on the genetics of male infertility in the era of next-generation sequencing ABGCKA Fakhroab Arab Journal of Urology 16 (1), 53-64, 2018 | 48 | 2018 |
| Longitudinal DNA methylation differences precede type 1 diabetes RK Johnson, LA Vanderlinden, F Dong, PM Carry, J Seifert, K Waugh, ... Scientific Reports 10 (1), 3721, 2020 | 43 | 2020 |
| Metformin in adults with type 1 diabetes: D esign and methods of REducing with MetfOrmin V ascular A dverse L esions (REMOVAL): A n international multicentre trial JR Petrie, N Chaturvedi, I Ford, I Hramiak, AD Hughes, AJ Jenkins, ... Diabetes, Obesity and Metabolism 19 (4), 509-516, 2017 | 39 | 2017 |
| Survival of autoreactive T lymphocytes by microRNA-mediated regulation of apoptosis through TRAIL and Fas in type 1 diabetes VM De Jong, AR Van Der Slik, S Laban, R van‘t Slot, BPC Koeleman, ... Genes & Immunity 17 (6), 342-348, 2016 | 38 | 2016 |
| miR-216a-targeting theranostic nanoparticles promote proliferation of insulin-secreting cells in type 1 diabetes animal model P Wang, Q Liu, H Zhao, JO Bishop, G Zhou, LK Olson, A Moore Scientific reports 10 (1), 5302, 2020 | 31 | 2020 |
| Natural products as chemo-radiation therapy sensitizers in cancers S Nisar, T Masoodi, KS Prabhu, S Kuttikrishnan, L Zarif, S Khatoon, S Ali, ... Biomedicine & Pharmacotherapy 154, 113610, 2022 | 27 | 2022 |
| Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments G Dagar, A Gupta, T Masoodi, S Nisar, M Merhi, S Hashem, R Chauhan, ... Journal of translational medicine 21 (1), 449, 2023 | 23 | 2023 |
| Integration of CRISPR/Cas9 with artificial intelligence for improved cancer therapeutics AA Bhat, S Nisar, S Mukherjee, N Saha, N Yarravarapu, SN Lone, ... Journal of translational medicine 20 (1), 534, 2022 | 19 | 2022 |
| Melanocortin‐4 receptor complexity in energy homeostasis, obesity and drug development strategies MT Fatima, I Ahmed, KA Fakhro, ASAS Akil Diabetes, Obesity and Metabolism 24 (4), 583-598, 2022 | 16 | 2022 |
| Machine learning workflows identify a microRNA signature of insulin transcription in human tissues WKM Wong, MV Joglekar, V Saini, G Jiang, CX Dong, A Chaitarvornkit, ... Iscience 24 (4), 2021 | 15 | 2021 |
| The role of dietary antioxidants in type 2 diabetes and neurodegenerative disorders: An assessment of the benefit profile MT Fatima, AA Bhat, S Nisar, KA Fakhro, ASAS Akil Heliyon 9 (1), 2023 | 13 | 2023 |
| Reading between the (genetic) lines: how epigenetics is unlocking novel therapies for type 1 diabetes ASALS Akil, LF Jerman, E Yassin, SS Padmajeya, A Al-Kurbi, KA Fakhro Cells 9 (11), 2403, 2020 | 10 | 2020 |
| Ethnic-specific association of amylase gene copy number with adiposity traits in a large Middle Eastern biobank N Rossi, E Aliyev, A Visconti, ASA Akil, N Syed, W Aamer, SS Padmajeya, ... NPJ Genomic Medicine 6 (1), 8, 2021 | 8 | 2021 |
| Pancreatic Islet Biology AA Hardikar Springer, 2016 | 7 | 2016 |
| Epigenetic modifications: Key players in cancer heterogeneity and drug resistance HQ Sadida, A Abdulla, S Al Marzooqi, S Hashem, MA Macha, ASAS Akil, ... Translational Oncology 39, 101821, 2024 | 6 | 2024 |
Ajaz BhatVanderbilt University Medical School , Sidra Medical and Research Center, Sylvester ComprehensiveVerified email at sidra.org
